BioNTech SE (BNTX) Invested Capital (2018 - 2026)

BioNTech SE has reported Invested Capital for 8 years, with the latest figure at $1.5 billion in Q4 2025.

• Quarterly Invested Capital fell 37.34% year-over-year to $1.5 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.8 billion (down 4.32% YoY) and the FY2025 annual result came in at $1.4 billion, down 39.18% from the prior year.
• Invested Capital advanced to $1.5 billion in Q4 2025 per BNTX's latest filing, from $698.4 million in the prior quarter.
• Over five years, Invested Capital peaked at $2.3 billion in Q4 2024 and troughed at $6.2 million in Q4 2022.
• A 5-year average of $674.6 million and a median of $431.7 million in 2025 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2022 and 2024: Invested Capital sank 99.67% in 2022, then surged 5457.68% in 2024.
• Over 5 years, Invested Capital stood at $1.9 billion in 2021, then tumbled by 99.67% to $6.2 million in 2022, then jumped by 570.79% to $41.7 million in 2023, then soared by 5457.68% to $2.3 billion in 2024, then slumped by 37.34% to $1.5 billion in 2025.
• According to Business Quant data, Invested Capital over the past three periods registered $1.5 billion, $698.4 million, and $164.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.